These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30108111)

  • 1. Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis.
    Nayak MK; Dhanesha N; Doddapattar P; Rodriguez O; Sonkar VK; Dayal S; Chauhan AK
    Blood Adv; 2018 Aug; 2(15):2029-2038. PubMed ID: 30108111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis.
    Flora GD; Nayak MK; Ghatge M; Kumskova M; Patel RB; Chauhan AK
    Blood Adv; 2023 Jun; 7(11):2347-2359. PubMed ID: 36971790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial calcium uniporter b deletion inhibits platelet function and reduces susceptibility to arterial thrombosis.
    Ghatge M; Nayak MK; Flora GD; Kumskova M; Jain A; Patel RB; Lin Z; Usachev YM; Chauhan AK
    J Thromb Haemost; 2023 Aug; 21(8):2163-2174. PubMed ID: 37061131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A; Kant S; Singh SM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol-3,4,5-trisphosphate stimulates Ca(2+) elevation and Akt phosphorylation to constitute a major mechanism of thromboxane A2 formation in human platelets.
    Kassouf N; Ambily A; Watson S; Hassock S; Authi HS; Srivastava S; Watson SP; Authi KS
    Cell Signal; 2015 Jul; 27(7):1488-98. PubMed ID: 25797048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis.
    Nayak MK; Ghatge M; Flora GD; Dhanesha N; Jain M; Markan KR; Potthoff MJ; Lentz SR; Chauhan AK
    Blood; 2021 Mar; 137(12):1658-1668. PubMed ID: 33027814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis.
    Zhang Y; Zhang J; Yan R; Tian J; Zhang Y; Zhang J; Chen M; Cui Q; Zhao L; Hu R; Jiang M; Li Z; Ruan C; He S; Dai K
    Proc Natl Acad Sci U S A; 2017 Mar; 114(11):2964-2969. PubMed ID: 28242694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis.
    Delaney MK; Kim K; Estevez B; Xu Z; Stojanovic-Terpo A; Shen B; Ushio-Fukai M; Cho J; Du X
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):846-54. PubMed ID: 26988594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
    Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fruitflow inhibits platelet function by suppressing Akt/GSK3β, Syk/PLCγ2 and p38 MAPK phosphorylation in collagen-stimulated platelets.
    Chen H; Zhang S; Wang H; Bao L; Wu W; Qi R
    BMC Complement Med Ther; 2022 Mar; 22(1):75. PubMed ID: 35300669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptors.
    Luo Q; Wei G; Wu X; Tang K; Xu M; Wu Y; Liu Y; Li X; Sun Z; Ju W; Qi K; Chen C; Yan Z; Cheng H; Zhu F; Li Z; Zeng L; Xu K; Qiao J
    J Transl Med; 2018 Nov; 16(1):311. PubMed ID: 30442147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate.
    Ferriero R; Iannuzzi C; Manco G; Brunetti-Pierri N
    J Inherit Metab Dis; 2015 Sep; 38(5):895-904. PubMed ID: 25601413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells.
    Ho N; Coomber BL
    Exp Cell Res; 2015 Feb; 331(1):73-81. PubMed ID: 25536473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
    Stacpoole PW
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.
    Michelakis ED; Gurtu V; Webster L; Barnes G; Watson G; Howard L; Cupitt J; Paterson I; Thompson RB; Chow K; O'Regan DP; Zhao L; Wharton J; Kiely DG; Kinnaird A; Boukouris AE; White C; Nagendran J; Freed DH; Wort SJ; Gibbs JSR; Wilkins MR
    Sci Transl Med; 2017 Oct; 9(413):. PubMed ID: 29070699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
    Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F
    Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models.
    Huang WC; Shu LH; Kuo YJ; Lai KS; Hsia CW; Yen TL; Hsia CH; Jayakumar T; Yang CH; Sheu JR
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
    Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.